Cyrus S. Poonawalla

Poonawalla in 2015 (2nd from right) Cyrus Soli Poonawalla (born 11 May 1941) is an Indian billionaire businessman, and the chairman and managing director of the Cyrus Poonawalla Group, which includes the Serum Institute of India, an Indian biotech company which is the largest vaccine manufacturer in the world, and Poonawalla Fincorp, a leading NBFC in India. In 2022, he was ranked as the 4th richest person in India on Forbes India rich list with a net worth of $24.3 billion. He was ranked number 1 on the Hurun Global Healthcare Rich List 2022.

In October 2024, Poonawalla and his family were ranked ninth on Forbes list of India’s 100 richest tycoons, with a net worth of $22.1 billion. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Cyrus S. Poonawalla', query time: 0.01s Refine Results
  1. 1
    Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults

    Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults by Prasad S. Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, Ashish Bavdekar, Madhu Gupta, Praveen Kulkarni, B.S. Garg, Nithya J. Gogtay, Muralidhar Tambe, Sanjay Lalwani, Kiranjit Singh, Renuka Munshi, Sushant Meshram, T.S. Selvavinayagam, Krishna Pandey, Devi Madhavi Bhimarasetty, S.R. Ramakrishnan, Chetanraj Bhamare, Abhijeet Dharmadhikari, Chandrashekhar Budhawant, Cyrille J. Bonhomme, Madhuri Thakar, Swarali N. Kurle, Elizabeth J. Kelly, Manish Gautam, Nivedita Gupta, Samiran Panda, Balram Bhargava, Cyrus S. Poonawalla, Umesh Shaligram, Dhananjay Kapse, Bhagwat Gunale

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: